DEVINTEC Pharma
Devintec Pharma is a pioneering company specializing in substance-based medical devices, with a focus on advanced research and development. They develop innovative solutions using DevinPro™, a patented technology that forms protective mucus-like barriers to treat various diseases. The company addresses unmet needs across multiple therapeutic areas including gastroenterology, dermatology, gynecology, and allergology. With a commitment to clinical proof, innovation, and cost-effectiveness, Devintec Pharma aims to improve patient outcomes and expand globally through licensing and partnerships.
Industries
Nr. of Employees
small (1-50)
DEVINTEC Pharma
Corso Elvezia 14 – 6900 Lugano, Switzerland
Products
Substance-based topical medical device for atopic dermatitis
Topical substance-based device intended to restore skin barrier function and relieve irritation, itching and redness to support natural healing in atopic dermatitis and related dermatitis.
Substance-based topical medical device for mild-to-moderate psoriasis
Topical device aimed at treating hyperkeratosis and skin plaques associated with mild to moderate plaque psoriasis.
Dermocosmetic hair and body wash with keratolytic and soothing actives
Cleansing formulation containing keratolytic and soothing ingredients intended for regular dermocosmetic use to support skin condition.
Substance-based nasal formulation for prevention and treatment of rhinitis/rhinosinusitis
Nasal formulation designed to avoid pathogen penetration by restoring tight junction structure and to control symptoms of rhinitis and rhinosinusitis.
Substance-based nasal formulation for congestion and sinusitis
Nasal formulation intended to fluidify excess mucus and promote mucus elimination to relieve nasal congestion associated with colds and sinusitis.
Substance-based intravaginal medical device for vaginal infections
Intravaginal formulation intended to prevent and treat vaginal infections by restoring tight junction structure and helping re-establish physiological vaginal pH.
Substance-based topical medical device for atopic dermatitis
Topical substance-based device intended to restore skin barrier function and relieve irritation, itching and redness to support natural healing in atopic dermatitis and related dermatitis.
Substance-based topical medical device for mild-to-moderate psoriasis
Topical device aimed at treating hyperkeratosis and skin plaques associated with mild to moderate plaque psoriasis.
Dermocosmetic hair and body wash with keratolytic and soothing actives
Cleansing formulation containing keratolytic and soothing ingredients intended for regular dermocosmetic use to support skin condition.
Substance-based nasal formulation for prevention and treatment of rhinitis/rhinosinusitis
Nasal formulation designed to avoid pathogen penetration by restoring tight junction structure and to control symptoms of rhinitis and rhinosinusitis.
Substance-based nasal formulation for congestion and sinusitis
Nasal formulation intended to fluidify excess mucus and promote mucus elimination to relieve nasal congestion associated with colds and sinusitis.
Substance-based intravaginal medical device for vaginal infections
Intravaginal formulation intended to prevent and treat vaginal infections by restoring tight junction structure and helping re-establish physiological vaginal pH.
Services
Licensing of developed substance-based medical device solutions to external partners, including negotiation of long-term agreements and exclusivity terms.
Licensing of developed substance-based medical device solutions to external partners, including negotiation of long-term agreements and exclusivity terms.
Expertise Areas
- Substance-based medical device development
- Barrier-restoring topical and mucosal formulations
- Clinical evidence generation for medical devices
- Regulatory compliance and CE marking for devices
Key Technologies
- Barrier-forming biomaterial technology
- Topical formulation chemistry
- Nasal spray formulation
- Intravaginal formulation
News & Updates
30%+ turnover invested in 2019
Invested in Research & Development
7+ products
Currently approved and marketed products in several disease areas including Gastroenterology, allergology, gynecology, and dermatology.
20+ scientific research
Scientific research projects and prospective global expansion efforts.
60+ countries
Countries where products are approved and marketed, certifying their quality and innovativeness.
30%+ turnover invested in 2019
Invested in Research & Development
7+ products
Currently approved and marketed products in several disease areas including Gastroenterology, allergology, gynecology, and dermatology.
20+ scientific research
Scientific research projects and prospective global expansion efforts.
60+ countries
Countries where products are approved and marketed, certifying their quality and innovativeness.